The implications of OS in hepatic diseases in dogs have been studied through the quantification of oxidants and antioxidants in various samples, such as blood, urine, and liver tissue, using a range of methods [90,91,92,93,94,95,96,97,98,99,100,101,102,103,104]
In a clinical trial in the same region in 1987-1990, 226 individuals with evidence of chronic hepatitis B infection were supplemented daily with either 200 g of selenium in the form of a selenium-enriched yeast tablet or a placebo yeast tablet
In addition, real-world use is frequently confounded by co-administration of multiple agents and inconsistent sourcing, limiting external validity and complicating attribution of benefit or harm
Some available options include: Wegovy (semaglutide in a higher dose) Specifically approved for treating obesity, Wegovy has been shown to lead to up to 15% body weight loss
Mounjaros cardiovascular outcomes trial (SURMOUNT-MMO) is due to be published soon